Group 1 - In August 2025, the Hong Kong Stock Exchange (HKEX) saw 6 new IPOs raising a total of 53.86 billion HKD, with Tianyue Advanced and Jiaxin International Resources leading the fundraising efforts at 20.44 billion HKD and 13.79 billion HKD respectively [1][2] - The overall trend indicates a slowdown in IPO activity since June 2025, with only 58 new IPOs raising over 134.1 billion HKD from January to August 2025 [2][6] - As of August 31, 2025, there are 234 companies in the IPO queue on HKEX, with 124 on the main board and 5 having passed the hearing [1][6] Group 2 - Tianyue Advanced, listed on August 20, 2025, had an issue price of 42.8 HKD per share and saw a first-day closing increase of 6.4%, although its stock price has since declined to 44.1 HKD [5] - Silver Pharmaceutical, which focuses on diabetes and metabolic disease treatments, had an issue price of 18.68 HKD per share and experienced a first-day price surge of over 200%, but has since dropped to around 42 HKD [5] - Major companies like Luxshare Precision and others are continuing to pursue IPOs in Hong Kong, indicating ongoing interest in the "A+H" market strategy [9]
【看新股】港股IPO月度透视:8月IPO募资超53亿港元 天岳先进、佳鑫国际资源募资额居前